Related Experiment Videos
Effect of phosphophoryn on rhBMP-2-induced bone formation
Takashi Saito1, Fumito Kobayashi, Takeo Fujii
1Department of Operative Dentistry and Endodontology, School of Dentistry, Health Sciences University of Hokkaido, 1757 Tobetsu, Hokkaido 061-0293, Japan. t-saito@hoku-iryo-u.ac.jp
Archives of Oral Biology
|January 17, 2004
Summary
Dentin phosphophoryn (DPP) enhances bone formation when used with recombinant human bone morphogenetic protein-2 (rhBMP-2). This DPP/rhBMP-2 combination shows greater bone regeneration in rats compared to rhBMP-2 alone.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedic Research
Background:
- Recombinant human bone morphogenetic protein-2 (rhBMP-2) is crucial for bone regeneration.
- Investigating co-factors to enhance rhBMP-2 efficacy is vital for clinical applications.
- Dentin phosphophoryn (DPP) is a major non-collagenous protein in dentin.
Purpose of the Study:
- To evaluate dentin phosphophoryn (DPP) as a co-factor for recombinant human bone morphogenetic protein-2 (rhBMP-2).
- To assess the effect of DPP on rhBMP-2-induced bone formation in a rat model.
Main Methods:
- rhBMP-2 was combined with DPP cross-linked to type I collagen as a composite carrier.
- Composites were implanted via onlay-grafting beneath the cranial periosteum in Wistar rats.
- Bone formation and composite degradation were analyzed at 2 and 3 weeks post-implantation.
Main Results:
- The rhBMP-2/DPP/collagen composite induced significantly more bone formation than the rhBMP-2/collagen composite.
- The rhBMP-2/DPP/collagen composite exhibited a faster degradation rate in vivo.
- DPP/collagen or collagen alone did not induce bone formation.
Conclusions:
- Dentin phosphophoryn (DPP) acts as an effective co-factor, enhancing the bone-inducing activity of rhBMP-2 in vivo.
- DPP/rhBMP-2/collagen composites show promise for promoting bone regeneration.
- This study highlights DPP's potential role in optimizing bone regenerative therapies.